Clinical Trial Update: A Phase 2 Study Using Placenta Derived Decidual Stromal Cells for Graft Versus Host Disease [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating placenta-derived decidual stromal cells for treating graft-versus-host disease; status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Placenta-Derived Decidual Stromal Cells (decidual stromal cells)

Snippet

Sponsor: Karolinska Institutet | Conditions: Graft vs Host Disease | Phase 1, Phase 2 | Status: UNKNOWN